Lavinia-Patricia Mocan (Lavinia Patricia Mocan)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Clinical Practice

Prognostic Factors

Small Cell Lung Cancer

Top Venues

Diagnostics (Basel, Switzerland)

Cancer immunology, immunotherapy : CII

Dermatologic therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Piekuś-Słomka, Lavinia-Patricia Mocan, Rezarta Shkreli, Cristiana Grapă, Kinga Denkiewicz, Oliwia Wesolowska, Miroslaw T Kornek, Zeno Spârchez, Artur Słomka, Rares Craciun, Tudor Mocan
Don't Judge a Book by Its Cover: The Role of Statins in Liver Cancer. Cancers 15 (20) (2023)
Zeno Spârchez, Rares Craciun, Iuliana Nenu, Lavinia-Patricia Mocan, Mihaela Spârchez, Tudor Mocan
Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications. Biomedicines 11 (8) (2023)
Lavinia-Patricia Mocan, Ioana Rusu, Carmen Stanca Melincovici, Bianca Adina Boșca, Tudor Mocan, Rareș Crăciun, Zeno Spârchez, Maria Ilieș, Carmen Mihaela Mihu
The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Lavinia-Patricia Mocan, Ioana Rusu, Carmen Stanca Melincovici, Bianca Adina Boșca, Tudor Mocan, Rareș Crăciun, Zeno Spârchez, Maria Ilieș, Carmen Mihaela Mihu
The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value. Diagnostics (Basel, Switzerland) 13 (9) (2023)
Olivia-Cornelia Trica, Lavinia-Patricia Mocan, Ruxandra Boit-Trapcea
Mepolizumab is highly effective in a rare case of Wells syndrome: Eosinophilic granulomatosis with polyangiitis overlap. Dermatologic therapy 35 (11) (2022)
Lavinia-Patricia Mocan, Rares Craciun, Cristiana Grapa, Carmen Stanca Melincovici, Ioana Rusu, Nadim Al Hajjar, Zeno Spârchez, Daniel-Corneliu Leucuta, Maria Ilieș, Mihaela Spârchez, Tudor Mocan, Carmen Mihaela Mihu
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma. Cancer immunology, immunotherapy : CII (2022)